Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christine M Lusk

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Cancer Medicine|October 23, 2021
Chemotherapy-induced peripheral neuropathy in African American cancer survivors: Risk factors and quality of life outcomesMatthew R Trendowski, Christine M Lusk, Julie J Ruterbusch, et al.
Cancer Medicine|June 3, 2022
Evaluation of health behaviors and overall quality of life in younger adult African American cancer survivorsMatthew R Trendowski, Jaclyn M Kyko, Christine M Lusk, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 2, 2024
Evaluation of the Immune Response within the Tumor Microenvironment in African American and Non-Hispanic White Patients with Non-Small Cell Lung CancerMatthew R Trendowski, Donovan Watza, Christine M Lusk, et al.
Cancer|October 27, 2021
The impact of the COVID-19 pandemic on African American cancer survivorsJennifer L Beebe-Dimmer, Christine M Lusk, Julie J Ruterbusch, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 16, 2019
Quantitative Imaging Markers of Lung Function in a Smoking Population Distinguish COPD Subgroups with Differential Lung Cancer RiskChristine M Lusk, Angela S Wenzlaff, Donovan Watza, et al.
American Journal of Human Genetics|August 19, 2025
Genetic analysis in African ancestry populations reveals genetic contributors to lung cancer susceptibilityMichael J Betti, James Jaworski, Shilin Zhao, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 8, 2016
Risk of Lung Cancer Associated with COPD Phenotype Based on Quantitative Image AnalysisAnn G Schwartz, Christine M Lusk, Angela S Wenzlaff, et al.
The Lancet. Oncology|January 23, 2016
Everolimus versus sunitinib for patients with metastatic non-clear cell renal cell carcinoma (ASPEN): a multicentre, open-label, randomised phase 2 trialAndrew J Armstrong, Susan Halabi, Tim Eisen, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 8, 2018
Rare Variants in Known Susceptibility Loci and Their Contribution to Risk of Lung CancerYanhong Liu, Christine M Lusk, Michael H Cho, et al.
NPJ Precision Oncology|February 17, 2021
Rare deleterious germline variants and risk of lung cancerYanhong Liu, Jun Xia, James McKay, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Cancer Medicine|October 23, 2021
Chemotherapy-induced peripheral neuropathy in African American cancer survivors: Risk factors and quality of life outcomesMatthew R Trendowski, Christine M Lusk, Julie J Ruterbusch, et al.
Cancer Medicine|June 3, 2022
Evaluation of health behaviors and overall quality of life in younger adult African American cancer survivorsMatthew R Trendowski, Jaclyn M Kyko, Christine M Lusk, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 2, 2024
Evaluation of the Immune Response within the Tumor Microenvironment in African American and Non-Hispanic White Patients with Non-Small Cell Lung CancerMatthew R Trendowski, Donovan Watza, Christine M Lusk, et al.
Cancer|October 27, 2021
The impact of the COVID-19 pandemic on African American cancer survivorsJennifer L Beebe-Dimmer, Christine M Lusk, Julie J Ruterbusch, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 16, 2019
Quantitative Imaging Markers of Lung Function in a Smoking Population Distinguish COPD Subgroups with Differential Lung Cancer RiskChristine M Lusk, Angela S Wenzlaff, Donovan Watza, et al.
American Journal of Human Genetics|August 19, 2025
Genetic analysis in African ancestry populations reveals genetic contributors to lung cancer susceptibilityMichael J Betti, James Jaworski, Shilin Zhao, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 8, 2016
Risk of Lung Cancer Associated with COPD Phenotype Based on Quantitative Image AnalysisAnn G Schwartz, Christine M Lusk, Angela S Wenzlaff, et al.
The Lancet. Oncology|January 23, 2016
Everolimus versus sunitinib for patients with metastatic non-clear cell renal cell carcinoma (ASPEN): a multicentre, open-label, randomised phase 2 trialAndrew J Armstrong, Susan Halabi, Tim Eisen, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 8, 2018
Rare Variants in Known Susceptibility Loci and Their Contribution to Risk of Lung CancerYanhong Liu, Christine M Lusk, Michael H Cho, et al.
NPJ Precision Oncology|February 17, 2021
Rare deleterious germline variants and risk of lung cancerYanhong Liu, Jun Xia, James McKay, et al.
Pageof 2